Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Comment: Should the EC look again at its regulatory armoury?

This article was originally published in Clinica

Executive Summary

Once again, it is the issue of breast implants that brings to the fore some unsettling questions about the way the EU's medical device regulatory system is working. This time, it is the European Commission's paper on how member states have responded to its Communication on Community and National Measures in relation to Breast Implants that raises questions over the best approach to addressing doubts about the ability of the medical device directives to guarantee the safety of potentially high-risk products.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT061289

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel